申请人:Cancer Targeted Technology LLC
公开号:US20190309000A1
公开(公告)日:2019-10-10
Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells.